Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial

A M van Rij1, C Solomon, S G Packer

  • 1Department of Surgery, University of Otago Medical School, Dunedin, New Zealand.

Circulation
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discrepancies between clinical diagnoses and autopsy findings: A comparative study conducted in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2022
Same author

Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously treated patients with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Optimising perioperative care for hip and knee arthroplasty in South Africa: a Delphi consensus study.

BMC musculoskeletal disorders·2018
Same author

Validity of an ultra-wideband local positioning system to measure locomotion in indoor sports.

Journal of sports sciences·2017
Same author

Comparison of citrated and fresh whole blood for viscoelastic coagulation testing during elective neurosurgery.

Thrombosis research·2017
Same author

Spatial and temporal analogies in microbial communities in natural drinking water biofilms.

The Science of the total environment·2017

Chelation therapy, using repeated intravenous infusions of EDTA, showed no significant benefits over placebo for intermittent claudication. This study found no improvement in walking distance or other health markers for patients receiving chelation therapy.

Area of Science:

  • Vascular Medicine
  • Clinical Trials
  • Pharmacology

Background:

  • Chelation therapy, involving intravenous EDTA infusions, is promoted for intermittent claudication and other conditions.
  • Despite anecdotal reports, a lack of robust studies has limited its clinical acceptance.
  • This study aimed to rigorously evaluate chelation therapy's efficacy in intermittent claudication patients.

Purpose of the Study:

  • To assess the clinical benefits of chelation therapy compared to placebo in patients diagnosed with intermittent claudication.

Main Methods:

  • A double-blind, randomized, controlled trial was conducted with 32 intermittent claudication patients.
  • Patients were allocated to either chelation therapy (15) or a placebo (17).
  • Outcomes included walking distance, ankle/brachial pulse indices, lifestyle, and cardiac/renal function.

Related Experiment Videos

Main Results:

  • No significant differences were observed in walking distance or ankle/brachial pulse indices between groups at 3 months.
  • Subjective measures of quality of life and daily activities showed no consistent improvement with chelation therapy.
  • The proportion of patients reporting improved walking distance was similar in both the chelation and placebo groups (60% vs. 59%).

Conclusions:

  • Chelation therapy demonstrated no significant beneficial effects compared to placebo in patients with intermittent claudication.
  • The findings do not support the use of chelation therapy for this condition.
  • Further research may be needed to explore alternative treatments for intermittent claudication.